Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
16
2016
What FDA Regulations Apply to Secondary Packaging of Reusable Spoons? Keller and Heckman LLP
Mar
16
2016
Are There Any Regulations Regarding a "Nutritious" Claim on Food Products? Keller and Heckman LLP
Mar
16
2016
New Mandatory GM Labeling Bill Introduced in the Senate Keller and Heckman LLP
Mar
16
2016
Biosecurity Best Practices Gaining Awareness on Michigan Farms Varnum LLP
Mar
16
2016
CDC Releases First National Standards Regarding Prescription Painkillers Dinsmore & Shohl LLP
Mar
16
2016
Montana’s Revised Medical Marijuana Law Survives Constitutional Challenge Jackson Lewis P.C.
Mar
16
2016
Genetically Modified Labeling: Congressional Compromise? Keller and Heckman LLP
Mar
16
2016
Federal Issues, Nanotechnology, FDA, Renewable Products: Clients and Friends Memorandum Bergeson & Campbell, P.C.
Mar
16
2016
CDC Issues New Guidelines for Opioid Painkiller Prescriptions McDermott Will & Emery
Mar
15
2016
PTAB Institutes Kyle Bass IPR Against Pharmaceutical Patent Based On SEC Document Foley & Lardner LLP
Mar
15
2016
Massachusetts Adopts Comprehensive Legislation To Curb Opioid Abuse McDermott Will & Emery
Mar
15
2016
Tackling Drug Prices: CMS and PhRMA Propose Steps to Promote Value-Based Purchasing Mintz
Mar
15
2016
Genetically Modified Updates: Chipotle & Congress Keller and Heckman LLP
Mar
15
2016
PTAB Institutes Kyle Bass IPRs Against Juxtapid Patents Foley & Lardner LLP
Mar
14
2016
A Practical Understanding of the Polymer Exemption Keller and Heckman LLP
Mar
14
2016
Expanded Crop Insurance Options for Farmers Transitioning to Certified Organic Agriculture Varnum LLP
Mar
14
2016
FDA Delays Enforcement of Restaurant Menu Labeling Rule McDermott Will & Emery
Mar
14
2016
POM Wonderful and Coca Cola: Trial by Jury Keller and Heckman LLP
Mar
14
2016
CMS Proposed Rule Reduces Drug Payments & Requires Implementation of Value-Based Purchasing Tools Foley & Lardner LLP
Mar
13
2016
OECD Publishes Reports on Physical-Chemical Properties and Categorization of Nanomaterials Bergeson & Campbell, P.C.
Mar
13
2016
EPA Issues Notice to Cancel Flubendiamide Registrations Bergeson & Campbell, P.C.
Mar
11
2016
EPA Defends Conditional Nanosilver Registration Bergeson & Campbell, P.C.
Mar
11
2016
Amarin/FDA Settlement: A Significant First Amendment Victory for Off-Label Marketing Mintz
Mar
11
2016
Acrylamide Guide Keller and Heckman LLP
Mar
11
2016
European Medicines Agency (EMA) Publishes Proactive Disclosure Guidance Covington & Burling LLP
Mar
11
2016
French Ministry Publishes Report on Nanomaterial Registrations Received in 2015 Bergeson & Campbell, P.C.
Mar
10
2016
Revised FDA Guidance Concerning Dietary Supplements Labeling Morgan, Lewis & Bockius LLP
Mar
10
2016
FDA and Amarin Reach Settlement on First Amendment and Off-Label Statements Morgan, Lewis & Bockius LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins